Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Saunders

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
Journal of Surgical Oncology|July 16, 2024
Preoperative chemotherapy response and survival in patients with colorectal cancer peritoneal metastasesNadina Tinsley, Sarah T O'Dwyer, Raghavendar Nagaraju, et al.
Clinical Colorectal Cancer|May 16, 2021
Three Versus Six Months of Adjuvant Doublet Chemotherapy for Patients With Colorectal Cancer: A Multi-Country Cost-Effectiveness and Budget Impact AnalysisCatherine R Hanna, Jose A Robles-Zurita, Andrew Briggs, et al.
Current Oncology (Toronto, Ont.)|December 27, 2024
Longitudinal Follow-Up of the Psychological Well-Being of Patients with Colorectal Cancer: Final Analysis of PICO-SMKonstantinos Kamposioras, Panagiotis Ntellas, Katerina Dadouli, et al.
Ecology Letters|August 24, 2006
Decoupling the direct and indirect effects of nitrogen deposition on ecosystem functionPete Manning, John E Newington, Helen R Robson, et al.
Cancers|February 25, 2023
The Mental Health Burden of Patients with Colorectal Cancer Receiving Care during the COVID-19 Pandemic: Results of the PICO-SM StudyKok Haw Jonathan Lim, Panagiotis Ntellas, Daniel Anderson, et al.
The Lancet. Oncology|December 3, 2020
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trialsThierry André, Jeffrey Meyerhardt, Timothy Iveson, et al.
British Journal of Cancer|September 1, 2017
Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutationsSimon Gollins, Nick West, David Sebag-Montefiore, et al.
Foodborne Pathogens and Disease|December 31, 2009
Virulotyping and antimicrobial resistance typing of Salmonella enterica serovars relevant to human health in EuropeStephan Huehn, Roberto M La Ragione, Muna Anjum, et al.
BMC Cancer|April 2, 2021
Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker studyReem D Mahmood, Danielle Shaw, Tine Descamps, et al.
JAMA Oncology|August 12, 2021
Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non-Small Cell Lung Cancer and Poor Performance Status: A Randomized Clinical TrialPuneeth Iyengar, Elizabeth Zhang-Velten, Laurence Court, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
Journal of Surgical Oncology|July 16, 2024
Preoperative chemotherapy response and survival in patients with colorectal cancer peritoneal metastasesNadina Tinsley, Sarah T O'Dwyer, Raghavendar Nagaraju, et al.
Clinical Colorectal Cancer|May 16, 2021
Three Versus Six Months of Adjuvant Doublet Chemotherapy for Patients With Colorectal Cancer: A Multi-Country Cost-Effectiveness and Budget Impact AnalysisCatherine R Hanna, Jose A Robles-Zurita, Andrew Briggs, et al.
Current Oncology (Toronto, Ont.)|December 27, 2024
Longitudinal Follow-Up of the Psychological Well-Being of Patients with Colorectal Cancer: Final Analysis of PICO-SMKonstantinos Kamposioras, Panagiotis Ntellas, Katerina Dadouli, et al.
Ecology Letters|August 24, 2006
Decoupling the direct and indirect effects of nitrogen deposition on ecosystem functionPete Manning, John E Newington, Helen R Robson, et al.
Cancers|February 25, 2023
The Mental Health Burden of Patients with Colorectal Cancer Receiving Care during the COVID-19 Pandemic: Results of the PICO-SM StudyKok Haw Jonathan Lim, Panagiotis Ntellas, Daniel Anderson, et al.
The Lancet. Oncology|December 3, 2020
Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trialsThierry André, Jeffrey Meyerhardt, Timothy Iveson, et al.
British Journal of Cancer|September 1, 2017
Preoperative chemoradiation with capecitabine, irinotecan and cetuximab in rectal cancer: significance of pre-treatment and post-resection RAS mutationsSimon Gollins, Nick West, David Sebag-Montefiore, et al.
Foodborne Pathogens and Disease|December 31, 2009
Virulotyping and antimicrobial resistance typing of Salmonella enterica serovars relevant to human health in EuropeStephan Huehn, Roberto M La Ragione, Muna Anjum, et al.
BMC Cancer|April 2, 2021
Effect of oxaliplatin plus 5-fluorouracil or capecitabine on circulating and imaging biomarkers in patients with metastatic colorectal cancer: a prospective biomarker studyReem D Mahmood, Danielle Shaw, Tine Descamps, et al.
JAMA Oncology|August 12, 2021
Accelerated Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Stage II/III Non-Small Cell Lung Cancer and Poor Performance Status: A Randomized Clinical TrialPuneeth Iyengar, Elizabeth Zhang-Velten, Laurence Court, et al.
Pageof 9